These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32432402)

  • 1. Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy.
    Athanasopoulos D; Motte J; Fisse AL; Grueter T; Trampe N; Sturm D; Tegenthoff M; Sgodzai M; Klimas R; Querol L; Gold R; Pitarokoili K
    Ann Clin Transl Neurol; 2020 Jun; 7(6):1061-1068. PubMed ID: 32432402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
    J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.
    Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC
    Muscle Nerve; 2018 May; 57(5):848-851. PubMed ID: 29130507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching Neuro
    Franques J; Chapon F; Devaux J; Mathis S
    Neurology; 2017 Feb; 88(7):e52. PubMed ID: 28193760
    [No Abstract]   [Full Text] [Related]  

  • 5. Optic, trigeminal, and facial neuropathy related to anti-neurofascin 155 antibody.
    Ogata H; Zhang X; Inamizu S; Yamashita KI; Yamasaki R; Matsushita T; Isobe N; Hiwatashi A; Tobimatsu S; Kira JI
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2297-2309. PubMed ID: 33080117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: Successfully treated with anti-CD20 monoclonal antibody.
    Sokmen O; Demirci M; Tan E
    Clin Neurol Neurosurg; 2021 Nov; 210():106961. PubMed ID: 34624826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study.
    Vallat JM; Mathis S; Magy L; Bounolleau P; Skarzynski M; Heitzmann A; Manso C; Devaux J; Uncini A
    Brain; 2018 Jul; 141(7):e56. PubMed ID: 29800077
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.
    Ogata H; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Isobe N; Kira JI
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2304-2316. PubMed ID: 31657126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy successfully treated with Cyclosporine A].
    Sato D; Ogata H; Kuwahara M; Kira J; Kusunoki S; Suzuki Y
    Rinsho Shinkeigaku; 2020 Aug; 60(8):533-537. PubMed ID: 32641627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
    Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
    Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
    Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
    J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
    Hu W; Xin Y; He Z; Zhao Y
    Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
    Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
    Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
    Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
    Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
    J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
    Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
    Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
    Vural A; Göçmen R; Kurne AT; Oğuz KK; Temuçin ÇM; Tan E; Karabudak R; Meinl E; Erdem Özdamar S
    Can J Neurol Sci; 2016 Jan; 43(1):149-56. PubMed ID: 26271726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
    Briani C; Salvalaggio A; Ruiz M; Cacciavillani M; Rinaldi F; Callegari I; Gasparotti R; Franciotta D
    J Neuroimmunol; 2019 May; 330():178-180. PubMed ID: 30713112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.